Ok, what is it that we can't see until 2025?
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
January 12, 2016
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Apricus Biosciences, Inc.
File No. 0-22245 -CF#33163
_____________________
Apricus Biosciences, Inc. submitted an application under Rule 24b-2 requesting
confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed
on November 5, 2015.
Based on representations by Apricus Biosciences, Inc. that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.1 through November 5, 2025
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Brent J. |
